• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于指尖全血中抗 RBD IgG 水平定量的机械检测方法。

A Mechanical Assay for the Quantification of Anti-RBD IgG Levels in Finger-Prick Whole Blood.

机构信息

Mechanobiology Institute, National University of Singapore, 117411, Singapore.

Department of Physics, National University of Singapore, 117542, Singapore.

出版信息

ACS Sens. 2023 Aug 25;8(8):2986-2995. doi: 10.1021/acssensors.3c00393. Epub 2023 Aug 15.

DOI:10.1021/acssensors.3c00393
PMID:37582229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10464602/
Abstract

A large portion of the global population has been vaccinated with various vaccines or infected with SARS-CoV-2, the virus that causes COVID-19. The resulting IgG antibodies that target the receptor binding domain (RBD) of SARS-CoV-2 play a vital role in reducing infection rates and severe disease outcomes. Different immune histories result in the production of anti-RBD IgG antibodies with different binding affinities to RBDs of different variants, and the levels of these antibodies decrease over time. Therefore, it is important to have a low-cost, rapid method for quantifying the levels of anti-RBD IgG in decentralized testing for large populations. In this study, we describe a 30 min assay that allows for the quantification of anti-RBD IgG levels in a single drop of finger-prick whole blood. This assay uses force-dependent dissociation of nonspecifically absorbed RBD-coated superparamagnetic microbeads to determine the density of specifically linked microbeads to a protein A-coated transparent surface through anti-RBD IgGs, which can be measured using a simple light microscope and a low-magnification lens. The titer of serially diluted anti-RBD IgGs can be determined without any additional sample processing steps. The limit of detection for this assay is 0.7 ± 0.1 ng/mL referenced to the CR3022 anti-RBD IgG. The limits of the technology and its potential to be further developed to meet the need for point-of-care monitoring of immune protection status are discussed.

摘要

全球很大一部分人口已经接种了各种疫苗或感染了导致 COVID-19 的 SARS-CoV-2 病毒。针对 SARS-CoV-2 受体结合域(RBD)的 IgG 抗体在降低感染率和严重疾病结局方面发挥着重要作用。不同的免疫史导致针对不同变体的 RBD 的抗 RBD IgG 抗体具有不同的结合亲和力,并且这些抗体的水平随时间而降低。因此,对于大量人群的分散式检测,拥有一种低成本、快速的定量检测抗 RBD IgG 水平的方法非常重要。在本研究中,我们描述了一种 30 分钟的测定方法,可在一滴手指刺破的全血中定量检测抗 RBD IgG 水平。该测定法使用力依赖性的非特异性吸收的 RBD 包被超顺磁微球的解离来确定通过抗 RBD IgGs 特异性连接的微球到蛋白 A 包被的透明表面的密度,这可以通过简单的显微镜和低倍镜头来测量。通过该测定法,无需任何额外的样品处理步骤即可确定抗 RBD IgG 的系列稀释液的效价。该测定法的检测限为 0.7 ± 0.1 ng/mL,以 CR3022 抗 RBD IgG 为参考。讨论了该技术的局限性及其进一步发展以满足即时护理监测免疫保护状态的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/6fcf6b126a23/se3c00393_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/bac4e0424ded/se3c00393_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/0a5000aaf25d/se3c00393_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/f2edd1cab542/se3c00393_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/aa06697438c9/se3c00393_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/ebb9bfe25c5e/se3c00393_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/6fcf6b126a23/se3c00393_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/bac4e0424ded/se3c00393_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/0a5000aaf25d/se3c00393_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/f2edd1cab542/se3c00393_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/aa06697438c9/se3c00393_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/ebb9bfe25c5e/se3c00393_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111b/10464602/6fcf6b126a23/se3c00393_0006.jpg

相似文献

1
A Mechanical Assay for the Quantification of Anti-RBD IgG Levels in Finger-Prick Whole Blood.一种用于指尖全血中抗 RBD IgG 水平定量的机械检测方法。
ACS Sens. 2023 Aug 25;8(8):2986-2995. doi: 10.1021/acssensors.3c00393. Epub 2023 Aug 15.
2
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.基于受体结合域的 ELISA 和 Luminex 预测德国和西班牙医护人员的两个纵向队列对 SARS-CoV-2 替代中和活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0316522. doi: 10.1128/spectrum.03165-22. Epub 2023 Jan 9.
3
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.不同类型疫苗的抗 SARS-CoV-2 RBD IgG 抗体反应的有效性和持续时间比较:对疫苗策略的影响。
Vaccine. 2022 May 3;40(20):2841-2847. doi: 10.1016/j.vaccine.2022.03.069. Epub 2022 Apr 1.
4
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.
5
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.化学发光免疫分析检测疫苗接种和康复 COVID-19 队列中中和抗体和结合抗体的纵向分布。
Immun Inflamm Dis. 2022 Jun;10(6):e612. doi: 10.1002/iid3.612.
6
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
7
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.日本对 BNT162b2 疫苗的抗体反应:通过测量针对 SARS-CoV-2 受体结合域的 IgG 抗体来监测疫苗效力。
Microbiol Spectr. 2022 Feb 23;10(1):e0118121. doi: 10.1128/spectrum.01181-21. Epub 2022 Jan 19.
8
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.埃塞俄比亚霍瓦萨地区学龄儿童中的 SARS-CoV-2 感染和 mRNA 疫苗诱导的体液免疫。
Front Immunol. 2023 Jun 15;14:1163688. doi: 10.3389/fimmu.2023.1163688. eCollection 2023.
9
Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand.泰国新冠肺炎和科兴疫苗接种后对严重急性呼吸综合征冠状病毒 2 变异株不同类别和亚类抗体反应的动态。
mSphere. 2023 Feb 21;8(1):e0046522. doi: 10.1128/msphere.00465-22. Epub 2023 Jan 23.
10
Bovine Serum Albumin-Protected Gold Nanoclusters for Sensing of SARS-CoV-2 Antibodies and Virus.牛血清白蛋白保护的金纳米团簇用于 SARS-CoV-2 抗体和病毒的检测。
ACS Appl Mater Interfaces. 2023 Jun 28;15(25):29914-29926. doi: 10.1021/acsami.3c03705. Epub 2023 Jun 14.

引用本文的文献

1
Force-dependent rapid immunoassay of high specificity and sensitivity.基于力的高特异性和高灵敏度快速免疫分析
Mechanobiol Med. 2024 Mar 21;2(2):100061. doi: 10.1016/j.mbm.2024.100061. eCollection 2024 Jun.

本文引用的文献

1
Acute and postacute sequelae associated with SARS-CoV-2 reinfection.与 SARS-CoV-2 再感染相关的急性和后期后遗症。
Nat Med. 2022 Nov;28(11):2398-2405. doi: 10.1038/s41591-022-02051-3. Epub 2022 Nov 10.
2
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.接种疫苗前 SARS-CoV-2 再感染的抗体保护相关性:SIREN 研究中的嵌套病例对照研究。
J Infect. 2022 Nov;85(5):545-556. doi: 10.1016/j.jinf.2022.09.004. Epub 2022 Sep 9.
3
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
在接受一剂BNT162b2疫苗加强针后,老年疗养院居民对新冠病毒奥密克戎变异株的中和抗体反应:一项基于社区的前瞻性纵向队列研究。
EClinicalMedicine. 2022 Jul 22;51:101576. doi: 10.1016/j.eclinm.2022.101576. eCollection 2022 Sep.
4
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.BA.2.12.1、BA.4 和 BA.5 逃避奥密克戎感染诱导的抗体。
Nature. 2022 Aug;608(7923):593-602. doi: 10.1038/s41586-022-04980-y. Epub 2022 Jun 17.
5
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.在 SARS-CoV-2 初免和既往感染人群中,BNT162b2 mRNA 疫苗对细胞和体液免疫应答的动力学和持久性:加强针和突破性感染的影响。
Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022.
6
Immune boosting by B.1.1.529 Omicron) depends on previous SARS-CoV-2 exposure.免疫增强作用取决于先前的 SARS-CoV-2 暴露情况。
Science. 2022 Jul 15;377(6603):eabq1841. doi: 10.1126/science.abq1841.
7
Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees.用于直接可视化新冠疫苗接种者中SARS-CoV-2抗体水平的微流控颗粒坝
Sci Adv. 2022 Jun 3;8(22):eabn6064. doi: 10.1126/sciadv.abn6064.
8
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis.COVID-19 疫苗对关注的 SARS-CoV-2 变异株的有效性:系统评价和荟萃分析。
BMC Med. 2022 May 23;20(1):200. doi: 10.1186/s12916-022-02397-y.
9
Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents.养老院居民接种第二剂和第三剂 BNT162b2 疫苗后抗刺突 IgG 抗体的动力学。
J Am Geriatr Soc. 2022 Sep;70(9):2552-2560. doi: 10.1111/jgs.17837. Epub 2022 May 10.
10
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.